Amer Zeidan, MBBS, MHS: Myelodysplastic syndromes [MDS] have, for a long time, been a disease entity that’s difficult to understand. There are misconceptions out there about myelodysplastic syndromes ...

Results show that it may be beneficial to add longitudinal monitoring of kidney function to the management of patients with MDS.

Bart Scott, MD, MS: Is MDS [myelodysplastic syndrome] really a cancer, and how does it relate to other cancers? It is considered to be a cancer. Beginning in about 2001, its diagnostic code was ...

Please provide your email address to receive an email when new articles are posted on . Olutasidenib monotherapy or combination therapy may help certain patients with myelodysplastic syndrome achieve ...

Dr. Shaal Patel, a board certified physician in hematology, oncology, and internal medicine, spoke with Healthline about how myelodysplastic syndromes (MDS) can benefit from supportive therapy, ...

Myelodysplastic syndromes, also called myelodysplasia or MDS, is the name for a group of conditions that cause the number of normal blood cells to drop. In these syndromes, the bone marrow does not ...

DelveInsight's,“ Myelodysplastic Syndrome Pipeline Insights 2025” report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It ...

The prognostic impact of monocytosis in patients with myelodysplastic syndromes (MDS) is not well-studied and not been clearly defined. Patients with MDS and monocytosis had a shorter overall survival ...

Please provide your email address to receive an email when new articles are posted on . Individuals who smoked had more genetic mutations associated with myelodysplastic syndrome than nonsmokers.